Subscribe to our newsletter and get the latest news from the Nordics straight to your inbox.
Serodus ASA is a Scandinavian drug development company, focusing on new therapeutic products for the treatment of diabetes and diabetic comorbidities with large unmet clinical needs.Serodus strives to increase shareholders value through advancing its portfolio to value-creating clinical milestones. With the current drug candidates supported by exceptional competencies to develop them, Serodus is uniquely positioned for successRead more
InDex conducts drug development and is located at Karolinska Institutet Science Park, in Stockholm.Read more
Sciety is an investment network that wants innovations that make a difference to reach their full potential and create value. We make it possible to invest in unlisted growth companies in the life science sector without having to spend time on selection, vetting and legal preparations. Our team has long experience in the finance and life science sectors and Sciety are authorised by the Swedish Financial Supervisory Authority.Read more
Mass Medical Angels (MA2) is a seed stage investor group exclusively focused on life science and healthcare investments. Our mission is to bring more clinical tools to the marketplace, while attaining superior returns for our investors. To do this, we provide financing and mentoring to early-stage life-science companies so that they can obtain further funding, reach positive cash-flows or get acquired.Read more